Warning: fopen(/home/virtual/jptm/journal/upload/ip_log/ip_log_2022-12.txt): failed to open stream: Permission denied in /home/virtual/lib/view_data.php on line 83 Warning: fwrite() expects parameter 1 to be resource, boolean given in /home/virtual/lib/view_data.php on line 84 Journal of Pathology and Translational Medicine
Skip Navigation
Skip to contents

JPTM : Journal of Pathology and Translational Medicine

OPEN ACCESS
SEARCH
Search

Articles

Page Path
HOME > J Pathol Transl Med > Volume 37(3); 2003 > Article
Original Article Secretion of TNF-alpha via Proteinase-Activated Receptor-2 in Human Astrocyte Cell Line.
Mi Sun Kim, Jin Ah Kim, Ok Hwa Kang, Ok Seon Baek, Jae Young Um, Jin Mu Yi, Ki Jung Yun, Hyung Min Kim, Young Mi Lee
Journal of Pathology and Translational Medicine 2003;37(3):159-165
DOI: https://doi.org/
  • 1,253 Views
  • 15 Download
  • 0 Crossref
  • 0 Scopus
1Department of Oriental Pharmacy, Collage of Pharmacy, Wonkwang University School of Medicine, Wonkwang University, Iksan, Korea.
2Department of Pathology, Wonkwang University School of Medicine, Wonkwang University, Iksan, Korea. ymlee@wonkwang.ac.kr

BACKGROUND
Proteinase-activated receptor 2 (PAR2) is cleaved, and it is activated by trypsin or mast cell tryptase. PAR2 plays an important role in inflammation. The aim of this study is to examine the potential of PAR2 agonists to modulate TNF-alpha secretion from the human astrocytoma cell line CCF-STTG1.
METHODS
PAR2 expression in CCF-STTG1 was examined using reverse transcriptase polymerase chain reaction and immunocytochemistry. The potential of PAR2 agonists to modulate TNF-alpha secretion from CCF-STTG1 was examined by enzyme-linked immunosorbent assays.
RESULTS
CCF-STTG1 expresses PAR2. PAR2 agonists such as trypsin, mast cell tryptase, and activating peptide SLIGKV-NH2 (corresponding to the PAR2 tethered ligand) directly signal CCF-STTG1 to induce the secretion of TNF-alpha but not in the case of the soybean trypsin inhibitor (SBTI) or VKGILS-NH2 (control peptide). Furthermore, the secretion of TNF-alpha was significantly reduced in CCF-STTG1 cells pre-treated with either 50 microM PD98059 (mitogen-activated protein/extracellular signal-regulated kinase kinase (MEK) inhibitor) or 1 microM SB203580 (p38 MAPK inhibitor) 30 min before trypsin stimulation.
CONCLUSIONS
These results show that trypsin may induce TNF-alpha secretion through the activation of MEK and p38 MAPK via PAR2 in astrocytoma cell line CCF-STTG1.

Related articles

JPTM : Journal of Pathology and Translational Medicine